Adherence to Renal Function Monitoring Guidelines in Patients Starting Antihypertensive Therapy with Diuretics and RAAS Inhibitors: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Adherence to Renal Function Monitoring Guidelines in Patients Starting Antihypertensive Therapy with Diuretics and RAAS Inhibitors: A Retrospective Cohort Study

Published:2014-04-19 Issue:5 Volume:37 Page:369-377
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

van Blijderveen Jan C.,Straus Sabine M.,de Ridder Maria A.,Stricker Bruno H.,Sturkenboom Miriam C.,Verhamme Katia M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-014-0160-0.pdf

Reference35 articles.

1. Jafar TH, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.

2. Gelfand ML, Garren MG, Rowan RL. Acute anuria associated with chlorothiazide and hydrochlorothiazide therapy: recovery. N Y State J Med. 1964;64:1865–70.

3. Pfeffer MA, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759–66.

4. Yusuf S, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–59.

5. Lapi F, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Learning to Embrace the Decline in eGFR After Initiation of Therapies for Heart Failure;Journal of the American College of Cardiology;2023-04

2. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity;The American Journal of Medicine;2022-12

3. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations;Circulation: Cardiovascular Quality and Outcomes;2020-09

4. Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes;Clinical Journal of the American Society of Nephrology;2019-08-08

5. Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury;Pharmacoepidemiology and Drug Safety;2019-04-30